OralPAS Pro®

INNOPHARMAX welcomes the opportunities to collaborate with strategic partners on co-development of partners’ assets/drug candidates utilizing INNOPHARMAX’s core drug delivery platforms OralPAS and OralPAS Pro

 

Inquiry on collaboration and additional information:business@innopharmax.com 
 
 
 


OralPAS Pro® platform, is a solid-SMEDDS dosage form composed of peptide drug, solvent, co-solvent, and surfactant adsorbed onto granules by inert excipients. Once platform is exposed to the fluids of gastrointestinal (GI) tract, peptide drug, surfactant and co-solvent are released from granules, and then rapidly spontaneously emulsify to form very fine globules (size, 100-200 nm) which entrap peptide drug in the nanoemulsion droplet core to against enzyme degradation and to enhance permeability, resulting in improvement of peptide drugs absorption through oral administration.



uGear Design - Website Info.